Delivery Order SPE2DB24D1107-SPE2DB25FZGD2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,130.64 to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML vials (10 ml) on September 10, 2025, with completion scheduled for September 11, 2025. This competitive award with firm fixed pricing represents a small-value pharmaceutical procurement utilizing no set-aside designation. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and falls under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract represents a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $1,472.06. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under...
- This delivery order, valued at $1,025.32, awards AmerisourceBergen Drug Corp the supply of Humalog 100 Unit/mL vials (10 mL) for the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and was competitively awarded without set-aside provisions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement to...
- The Defense Logistics Agency awarded a delivery order valued at $1,395.32 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Humalog 100 Unit/mL vials (10 mL). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award. This delivery order is a child contract under AmerisourceBergen...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.39, is for the delivery of Humalog 100 unit/mL vial, 10 mL. The contract is a firm fixed price type and has a completion date of June 7, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,267.94 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) under a firm fixed price contract. This award, announced on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $546 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml vials of Humalog insulin. The firm fixed price order calls for the delivery of 10 ml vials of the pharmaceutical to a facility in Conshohocken, Pennsylvania by July 28, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for Humalog supports the Agency's mission to provide essential products and services to...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGD2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,884.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical global pharmaceutical program, the company supplies a comprehensive range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Humalog, an insulin medication used in diabetes management, exemplifies the company's role in fulfilling federal pharmaceutical supply needs across the military healthcare supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/31/25 |